This compound is an active pharmaceutical ingredient impurity, specifically an ethyl ester derivative of a quinoline-based structure. It is referenced as a reference standard for quality control in pharmaceutical manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 148901-69-3
Pitavastatin Ethyl Ester
statin drug intermediate
Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate
active pharmaceutical ingredient impurity
RIFAMYCIN SODIUM
sodium salt antibiotic active ingredient
부틸스코폴라민브롬화물
antispasmodic active pharmaceutical ingredient
D-Norepinephrine
active pharmaceutical ingredient
Dexrazoxane hydrochloride
active pharmaceutical ingredient
Tert-Butyl pitavastatin
active pharmaceutical ingredient
(3R,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3-hydroxy-5-oxo-6-heptenoic acid
statin metabolite impurity
ethyl (E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-5-hydroxy-3-oxohept-6-enoate
DPBQVLWVWXLRGW-BUHFOSPRSA-N
CCOC(=O)CC(=O)CC(/C=C/C1=C(C2=CC=CC=C2N=C1C3CC3)C4=CC=C(C=C4)F)O
—